Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%

Follow WST

Alert me

Market cap: $27.0B
P/E: 48.7×
Fwd P/E: 37.3×
Dividend yield: 0.23%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	38.63	40.28	33.33	45.62
P/S ratio Full definition →		6.28	6.47	5.60	7.64
P/FCF ratio Full definition →		50.47	42.77	39.73	58.69
P/Operating CF Full definition →		96.05	79.22	200.74	204.98
P/B ratio Full definition →		6.21	6.26	6.03	8.50
Price to Tangible BV Full definition →		6.46	6.50	6.28	8.84
EV/Sales Full definition →		6.13	6.28	5.50	7.57
EV/EBITDA Full definition →		24.59	25.52	21.32	29.22
EV/Operating CF Full definition →		26.69	25.58	24.78	38.03
EV/FCF Full definition →		49.33	41.51	39.03	58.15
Quick Ratio Full definition →		1.97	2.09	1.79	1.79
Current Ratio Full definition →		2.87	3.02	2.71	2.82
Net Debt/EBITDA Full definition →		(2.02)	(2.89)	(1.43)	(1.03)
Debt/Assets Full definition →		4.94%	4.75%	4.93%	4.98%
Debt/Equity Full definition →		0.07	0.06	0.07	0.07
Asset Turnover Full definition →		0.78	0.78	0.83	0.83
Operating CF/Net income Full definition →		1.41	1.90	0.65	0.81
Capex/Depreciation Full definition →		(1.47)	(1.62)	(0.94)	(0.94)
Interest Coverage Full definition →		838.00	(783.00)	93.21	68.88
Research and Development Expense of Revenue Full definition →		2.13%	2.71%	1.87%	2.26%
Selling, General and Administrative Expense of Revenue Full definition →		12.76%	13.29%	11.78%	13.48%
Intangible Assets out of Total Assets Full definition →		0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →		1.04%	0.83%	0.78%	1.25%
Graham Net Nets Full definition →		0.04	0.04	0.04	0.03
Graham Number Full definition →		80.36	82.16	83.83	86.48
Earnings Yield Full definition →		2.59%	2.48%	3.00%	2.19%
Free Cash Flow Yield Full definition →		1.98%	2.34%	2.52%	1.70%
Revenue per Share Full definition →		11.14	11.13	11.73	12.32
Operating CF per Share Full definition →		2.73	3.47	1.25	1.75
Capex per Share Full definition →		(0.88)	(1.05)	(0.59)	(0.61)
Free Cash Flow per Share Full definition →		1.85	2.42	0.66	1.14
Cash per Share Full definition →		8.71	10.94	7.24	6.16
Shareholders Equity per Share Full definition →		42.26	43.93	41.53	42.23
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		42.26	43.93	41.53	42.23
Free Cash Flow Full definition →		133.90	175.00	47.20	80.80
Working Capital Full definition →		1,187.90	1,323.30	1,152.80	1,167.00
Capital Expenditures Full definition →		(63.30)	(76.10)	(42.70)	(43.20)
Net Current Asset Value Full definition →		769.00	884.20	707.40	721.30
EV/EBIT Full definition →		31.49	33.00	27.06	37.01
Capex to Sales Full definition →		0.08	0.09	0.05	0.05
Price to Operating Income Full definition →		32.22	34.01	27.55	37.36
Other line items
Average Receivables Full definition →		574.65	563.45	614.60	647.20
Average Payables Full definition →		240.05	246.50	240.35	245.85
Average Inventory Full definition →		419.60	410.45	420.65	434.25
Average Assets Full definition →		3,890.45	3,956.70	3,864.00	4,014.60
Average Common Equity Full definition →		2,901.80	2,929.15	2,836.75	2,959.65

Show all line items

Columns are period end dates

Stockrow Weekly